Complications after pelvic floor repair surgery (with and without mesh): short-term incidence after 1873 inclusions in the French VIGI-MESH registry.


Journal

BJOG : an international journal of obstetrics and gynaecology
ISSN: 1471-0528
Titre abrégé: BJOG
Pays: England
ID NLM: 100935741

Informations de publication

Date de publication:
01 2020
Historique:
accepted: 09 09 2019
pubmed: 24 9 2019
medline: 24 12 2019
entrez: 24 9 2019
Statut: ppublish

Résumé

To assess the short-term incidence of serious complications of surgery for urinary incontinence or pelvic organ prolapse. Prospective longitudinal cohort study using a surgical registry. Thirteen public hospitals in France. A cohort of 1873 women undergoing surgery between February 2017 and August 2018. Preliminary analysis of serious complications after a mean follow-up of 7 months (0-18 months), according to type of surgery. Surgeons reported procedures and complications, which were verified by the hospitals' information systems. Serious complication requiring discontinuation of the procedure or subsequent surgical intervention, life-threatening complication requiring resuscitation, or death. Fifty-two women (2.8%, 95% CI 2.1-3.6%) experienced a serious complication either during surgery, requiring the discontinuation of the procedure, or during the first months of follow-up, necessitating a subsequent reoperation. One woman also required resuscitation; no women died. Of 811 midurethral slings (MUSs), 11 were removed in part or totally (1.4%, 0.7-2.3%), as were two of 391 transvaginal meshes (0.5%, 0.1-1.6%), and four of 611 laparoscopically placed mesh implants (0.7%, 0.2-1.5%). The incidence of serious complications 6 months after the surgical procedure was estimated to be around 3.5% (2.0-5.0%) after MUS alone, 7.0% (2.8-11.3%) after MUS with prolapse surgery, 1.7% (0.0-3.8%) after vaginal native tissue repair, 2.8% (0.9-4.6%) after transvaginal mesh, and 1.0% (0.1-1.9%) after laparoscopy with mesh. Early serious complications are relatively rare. Monitoring must be continued and expanded to assess the long-term risk associated with mesh use and to identify its risk factors. Short-term serious complications are rare after surgery for urinary incontinence or pelvic organ prolapse, even with mesh.

Identifiants

pubmed: 31544327
doi: 10.1111/1471-0528.15956
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

88-97

Subventions

Organisme : Agence Nationale de Sécurité du Médicament et des Produits de Santé
Pays : International

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2019 Royal College of Obstetricians and Gynaecologists.

Références

Fritel X, Panjo H, Varnoux N, Ringa V. The individual determinants of care-seeking among middle-aged women reporting urinary incontinence: Analysis of a 2273-woman cohort. Neurourol Urodyn 2014;33:1116-22.
Fritel X, Varnoux N, Zins M, Bréart G, Ringa V. Symptomatic pelvic organ prolapse at midlife, quality of life, and risk factors. Obstet Gynecol 2009;113:609-16.
Baessler K, Christmann-Schmid C, Maher C, Haya N, Crawford TJ, Brown J. Surgery for women with pelvic organ prolapse with or without stress urinary incontinence. Cochrane Database Syst Rev 2018;8:CD013108.
Lucot JP, Cosson M, Bader G, Debodinance P, Akladios C, Salet-Lizée D, et al. Safety of vaginal mesh surgery versus laparoscopic mesh sacropexy for cystocele repair: results of the Prosthetic Pelvic Floor Repair randomized controlled trial. Eur Urol 2018;74:167-76.
Le Normand L, Cosson M, Cour F, Deffieux X, Donon L, Ferry P, et al. Clinical Practice Guidelines: Synthesis of the guidelines for the surgical treatment of primary pelvic organ prolapse in women by the AFU, CNGOF, SIFUD-PP, SNFCP, and SCGP. J Gynecol Obstet Hum Reprod 2017;46:387-91.
Afssaps. Bandelettes posées par voie vaginale, Rapport d’enquête. 2005. Available from: http://ansm.sante.fr/var/ansm_site/storage/original/application/5c67f2cb300d639de8df75f696e848ea.pdf.
Sarreau M, Bon D, Estrade V, Villemonteix P, Fritel X. Sexualité après cure d’incontinence urinaire par bandelette sous-urétrale transobturatrice et satisfaction des patientes. [Sexual function after transobturator tape procedure for stress urinary incontinence and overall patients’ satisfaction] Prog Urol 2016;26:24-33.
MRHA. A summary of the evidence on the benefits and risks of vaginal mesh implants. 2014. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/402162/Summary_of_the_evidence_on_the_benefits_and_risks_of_vaginal_mesh_implants.pdf.
Khanuengkitkong S, Lo TS, Dass AK. Delayed vaginal and urethral mesh exposure: 10 years after TVT surgery. Int Urogynecol J 2013;24:519-21.
Roth TM, Reight I. Laparoscopic mesh explantation and drainage of sacral abscess remote from transvaginal excision of exposed sacral colpopexy mesh. Int Urogynecol J 2012;23:953-5.
NHS Recommendations of the Mesh Pause Clinical Advisory Group to Medical Directors and Surgical Teams. Available from: https://www.baus.org.uk/_userfiles/pages/files/Patients/CAGmesh%20FINAL.pdf.
Utilisation des données d’un registre de chirurgie de l’incontinence et du prolapsus pour suivre les dispositifs médicaux concernés faisant partie du programme 2016 de surveillance renforcée des Dispositifs médicaux. Available from: https://ansm.sante.fr/var/ansm_site/storage/original/application/17ae0787d2339be6aba55cba02353ece.pdf.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications. Ann Surg 2004;240:205-13.
Haylen BT, Freeman RM, Swift SE, Cosson M, Davila GW, Deprest J, et al. An international urogynecological association (IUGA)/international continence society (ICS) joint terminology and classification of the complications related directly to the insertion of prostheses (meshes, implants, tapes) and grafts in female pelvic floor surgery. Neurourol Urodyn 2011;30:2-12.
Haylen BT, Freeman RM, Lee J, Swift SE, Cosson M, Deprest J, et al. International Urogynecological Association (IUGA)/International Continence Society (ICS) joint terminology and classification of the complications related to native tissue female pelvic floor surgery. Neurourol Urodyn 2012;31:406-14.
Fritel X, Campagne-Loiseau S, de Tayrac R, Ferry P, Saussine C, Garbin O et al.French observatory of pelvic floor repair surgery (with or without mesh), VIGI-MESH, first results after more than 1000 inclusions. IUGA 2018, Vienna. Available from: https://iugameeting.org/2018-meeting/program/?where_person=44.
Wang C, Christie AL, Zimmern PE. Synthetic mid-urethral sling complications: Evolution of presenting symptoms over time. Neurourol Urodyn 2018;37:1937-42.
Gurol-Urganci I, Geary RS, Mamza JB, Duckett J, El-Hamamsy D, Dolan L, et al. Long-term rate of mesh sling removal following midurethral mesh sling insertion among women with stress urinary incontinence. JAMA 2018;320:1659-69.
Tunitsky E, Abbott S, Barber MD. Interrater reliability of the Inter-national Continence Society and International Urogynecological Association (ICS/IUGA) classification system for mesh-related complications. Am J Obstet Gynecol 2012;206(442):e1-6.
Jacquetin B, Hinoul P, Gauld J, Fatton B, Rosenthal C, Clavé H, et al. Total transvaginal mesh (TVM) technique for treatment of pelvic organ prolapse: a 5-year prospective follow-up study. Int Urogynecol J 2013;24:1679-86.
Desseauve D, Pierre F, Fritel X. Urinary incontinence in women: study of surgical practice in France. Prog Urol 2013;23:249-55.
Cundiff GW, Quinlan DJ, van Rensburg JA, Slack M. Foundation for an evidence-informed algorithm for treating pelvic floor mesh complications: a review. BJOG 2018;125:1026-37.

Auteurs

X Fritel (X)

INSERM CIC 1402, CHU de Poitiers, Service de gynécologie-obstétrique, Université de Poitiers, Poitiers, France.
CESP Inserm U1018, Paris, France.

S Campagne-Loiseau (S)

CHU Estaing, Service de gynécologie-obstétrique, Clermont-Ferrand, France.

M Cosson (M)

CHU de Lille, Service de gynécologie-obstétrique, Université de Lille, Lille, France.

P Ferry (P)

CH de La Rochelle, Service de gynécologie-obstétrique, La Rochelle, France.

C Saussine (C)

CHU de Strasbourg, Service d'urologie, Université de Strasbourg, Strasbourg, France.

J-P Lucot (JP)

Hôpital Saint-Vincent-de-Paul, Service de gynécologie-obstétrique, Lille, France.

D Salet-Lizee (D)

Groupe Hospitalier Diaconesses-Croix-Saint-Simon, Service de gynécologie, Paris, France.

M-L Barussaud (ML)

CHU de Poitiers, Service de chirurgie viscérale, Poitiers, France.

T Boisramé (T)

CHU de Strasbourg, Service de gynécologie-obstétrique, Strasbourg, France.

C Carlier-Guérin (C)

CH de Châtellerault, Service de gynécologie-obstétrique, Châtellerault, France.

T Charles (T)

CHU de Poitiers, Service d'urologie, Poitiers, France.

P Debodinance (P)

CH de Dunkerque, Service de gynécologie-obstétrique, Dunkerque, France.

X Deffieux (X)

APHP Antoine-Béclère, Service de gynécologie-obstétrique, Université Paris-Sud, Clamart, France.

A-C Pizzoferrato (AC)

CHU de Caen, Service de gynécologie-obstétrique, Caen, France.

S Curinier (S)

CHU Estaing, Service de gynécologie-obstétrique, Clermont-Ferrand, France.

S Ragot (S)

INSERM CIC 1402, Université de Poitiers, Poitiers, France.

V Ringa (V)

CESP Inserm U1018, Paris, France.

R de Tayrac (R)

CHU Carémeau, Service de gynécologie-obstétrique, Université de Nîmes, Nîmes, France.

A Fauconnier (A)

CHI Poissy-Saint-Germain, Service de gynécologie-obstétrique, UVSQ, Poissy, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH